9,569 Oracle Corporation $ORCL Shares Sold by Quadrant Capital Group LLC

Quadrant Capital Group LLC lowered its stake in Oracle Corporation (NYSE:ORCL) by 12.9% during the third quarter, HoldingsChannel reports. The institutional investor owned 64,841 shares of the enterprise software provider’s stock after selling 9,569 shares during the quarter. Quadrant Capital Group LLC’s holdings in Oracle were worth $9,285,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in shares of Oracle by 0.8% during the second quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 14,680,278 shares of the enterprise software provider’s stock valued at $2,151,395,000 after acquiring an additional 123,294 shares during the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of Oracle by 3.0% in the 1st quarter. Bank of New York Mellon Corp now owns 13,251,059 shares of the enterprise software provider’s stock worth $1,949,363,000 after acquiring an additional 384,984 shares during the last quarter. Amundi lifted its holdings in shares of Oracle by 1.5% in the 2nd quarter. Amundi now owns 9,878,184 shares of the enterprise software provider’s stock worth $1,447,648,000 after acquiring an additional 144,087 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Oracle by 1.7% during the 1st quarter. Dimensional Fund Advisors LP now owns 8,586,492 shares of the enterprise software provider’s stock worth $1,262,827,000 after purchasing an additional 147,048 shares during the period. Finally, First Eagle Investment Management LLC boosted its position in shares of Oracle by 1.0% during the 2nd quarter. First Eagle Investment Management LLC now owns 8,516,878 shares of the enterprise software provider’s stock worth $1,248,148,000 after purchasing an additional 81,700 shares during the period. Hedge funds and other institutional investors own 42.44% of the company’s stock.

Analyst Ratings Changes

Several research firms recently weighed in on ORCL. UBS Group lifted their target price on shares of Oracle from $245.00 to $250.00 and gave the company a “buy” rating in a report on Friday, September 11th. President Capital decreased their price target on Oracle from $360.00 to $300.00 and set an “overweight” rating on the stock in a research note on Tuesday, July 14th. DZ Bank restated a “buy” rating on shares of Oracle in a research note on Thursday, September 17th. Oppenheimer restated an “outperform” rating and set a $275.00 price target (up from $235.00) on shares of Oracle in a research report on Tuesday, September 8th. Finally, Stifel Nicolaus dropped their price objective on Oracle from $220.00 to $200.00 and set a “buy” rating for the company in a research note on Friday, September 11th. One analyst has rated the stock with a Strong Buy rating, thirty-five have assigned a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $249.52.

Oracle News Summary

Here are the key news stories impacting Oracle this week:

• Positive Sentiment: Oracle announced a collaboration with AstraZeneca to use its cloud, AI, analytics and real-world health data to improve clinical-trial recruitment, accelerate evidence generation and connect research with patient care. The agreement broadens Oracle’s AI opportunity beyond data centers and healthcare applications could create additional long-term growth. Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
• Positive Sentiment: A BNP Paribas software-reseller survey reportedly showed an “impressive inflection” in Oracle demand, supporting the view that cloud, database and AI sales momentum is improving. Oracle’s multicloud database revenue also grew sharply, allowing customers to use Oracle databases alongside applications hosted on rival clouds. Oracle Sees Stronger AI Demand as BNP Paribas Survey Shows Major Improvement
• Positive Sentiment: TD Cowen suggested Nvidia may help finance Oracle’s AI data-center buildout, potentially reducing Oracle’s need to fund the expensive infrastructure directly. Bank of America also maintained a bullish outlook and cited substantial upside potential. Nvidia May Be Helping Finance Oracle’s AI Data Centers
• Neutral Sentiment: Oracle’s Project Jupiter data-center campus is reportedly progressing quickly, but the company’s efforts to use alternative financing and its reported force-majeure position highlight the execution and funding challenges of its massive AI expansion. Oracle Calls Force Majeure Already?
• Negative Sentiment: Credit concerns remain a major risk. Investors are questioning whether Oracle can fund its large AI buildout without putting pressure on its balance sheet, while rising borrowing costs have increased downgrade concerns for Oracle bonds. Analysts also warn that the stock may still be overvalued despite its recent decline. Oracle Bonds Face Downgrade Risks as AI Trade Fizzles

Insider Buying and Selling at Oracle

In other Oracle news, Director Stephen H. Rusckowski purchased 25,000 shares of the company’s stock in a transaction on Tuesday, September 29th. The stock was acquired at an average price of $139.35 per share, for a total transaction of $3,483,750.00. Following the completion of the purchase, the director directly owned 25,390 shares in the company, valued at approximately $3,538,096.50. The trade was a 6,410.26% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Michael D. Sicilia sold 22,562 shares of the company’s stock in a transaction on Tuesday, September 22nd. The stock was sold at an average price of $151.59, for a total value of $3,420,173.58. Following the sale, the chief executive officer directly owned 182,929 shares in the company, valued at $27,730,207.11. This represents a 10.98% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 36,075 shares of company stock valued at $5,342,123 in the last 90 days. Company insiders own 38.40% of the company’s stock.

Oracle Stock Up 0.9%

Shares of ORCL opened at $130.77 on Wednesday. The stock has a market capitalization of $395.42 billion, a PE ratio of 20.50, a P/E/G ratio of 0.91 and a beta of 1.78. Oracle Corporation has a 1 year low of $114.50 and a 1 year high of $287.19. The company has a debt-to-equity ratio of 1.89, a quick ratio of 1.17 and a current ratio of 1.17. The company’s 50-day simple moving average is $144.66 and its 200-day simple moving average is $158.56.

Oracle (NYSE:ORCL) last posted its quarterly earnings data on Thursday, September 10th. The enterprise software provider reported $1.92 EPS for the quarter, beating the consensus estimate of $1.74 by $0.18. The business had revenue of $19.34 billion during the quarter, compared to analyst estimates of $19.13 billion. Oracle had a net margin of 26.36% and a return on equity of 48.85%. The business’s revenue for the quarter was up 29.6% compared to the same quarter last year. During the same quarter last year, the firm posted $1.47 earnings per share. Oracle has set its Q2 2027 guidance at 1.850-1.930 EPS and its FY 2027 guidance at 8.100-8.100 EPS. Analysts forecast that Oracle Corporation will post 6.73 earnings per share for the current fiscal year.

Oracle Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 23rd. Shareholders of record on Friday, October 9th will be issued a dividend of $0.50 per share. The ex-dividend date is Friday, October 9th. This represents a $2.00 dividend on an annualized basis and a yield of 1.5%. Oracle’s dividend payout ratio is 31.35%.

About Oracle

Oracle Corporation (NYSE: ORCL) is a global technology company that develops enterprise software, cloud infrastructure and database technologies. Its products help organizations store, manage, analyze and secure data, while supporting business operations across industries and geographies.

The company’s offerings include Oracle Database, Java, Oracle Cloud Infrastructure and a broad portfolio of cloud-based applications. These applications serve functions such as enterprise resource planning, financial management, human resources, supply-chain management, customer experience and industry-specific operations.